A clinical and practical guide for women who have been told to “just relax” or push through the pain
Pain During Sex Is Never Just Something to Accept
Dyspareunia is the term used to describe genitopelvic pain that is provoked by sexual activity. It is a sexual problem, a diagnosis that merits treatment. Yet an enormous number of women are never told this. They are advised to use more lubricant, to relax, to drink a glass of wine – and when none of that works, they quietly stop having sex and say nothing more about it.
The prevalence of dyspareunia in the United States is approximately 10% to 20%, with leading causes varying by age group. The World Health Organization reported a global prevalence of painful intercourse ranging between 8% and 21.1%. Among perimenopausal and postmenopausal women, the figure is significantly higher.
Types of Pain: Location Tells You Everything
Not all sexual pain is the same – and where you feel it is one of the most diagnostically important pieces of information.
Entry (superficial) dyspareunia – pain at or just inside the vaginal opening – is most commonly associated with genitourinary syndrome of menopause (GSM), vulvodynia, inadequate lubrication, or pelvic floor dysfunction. Patients who have pain with vaginal entry may have atrophy, inadequate lubrication, pelvic floor dysfunction, vaginitis, vulvodynia, or vaginismus.
Deep dyspareunia – pain felt internally, in the pelvis or lower abdomen during deeper penetration – is more commonly linked to endometriosis, fibroids, ovarian cysts, pelvic inflammatory disease, or structural abnormalities such as uterine retroversion.
Vaginismus deserves its own mention. Vaginismus (involuntary contraction of the pelvic floor muscles with attempted vaginal penetration) leads to fear or anxiety about penetration, causing pelvic floor muscle constriction. Primary vaginismus occurs in patients who have never had painless penetration, whereas secondary vaginismus occurs when the patient previously had painless penetration but now reports pain. Secondary vaginismus can develop as a direct consequence of untreated dyspareunia – the body learns to protect itself from anticipated pain, creating a self-reinforcing cycle.
Vulvodynia is localized to the vulva and vaginal introitus. Whereas dyspareunia may be acute or chronic, vulvodynia is a term used specifically for the classification of chronic pain lasting longer than three months.
The Menopause–Pain Connection
Dyspareunia and sexual pain are cardinal symptoms of GSM, along with decreased or delayed orgasm, decreased arousal and lubrication, and secondary decrease of sexual desire. GSM overall may cause poor sexual satisfaction and resulting reactive pelvic floor hypertonus and vaginismus.
This cascade is worth understanding clearly. Estrogen-deprived vaginal tissue becomes thin, dry, and less elastic. Penetration that was previously comfortable becomes painful. In response, the pelvic floor may develop protective hypertonicity – chronic tightening to guard against anticipated pain. This tightness itself becomes a further cause of pain, even as the original tissue changes are addressed. Breaking this cycle requires treating both dimensions simultaneously.
Women who have comorbidities such as endometriosis, fibroids, or vaginitis related to dyspareunia also have lower sexual function that causes relationship distress with their partners and decreases their quality of life. Studies have also shown a significant correlation between sexual pain and psychiatric comorbidities such as depression and anxiety. Pain during sex does not exist in isolation – it affects mood, self-image, and relationship quality, which in turn affect pain perception. A holistic approach is essential.
What a Proper Evaluation Looks Like
If you present with dyspareunia to a well-trained clinician, the evaluation should include a detailed sexual history (when does the pain occur, where is it located, how long has it been present, what makes it better or worse), a careful external genital inspection, a single-digit internal examination before any speculum is introduced, and assessment of pelvic floor muscle tone and tenderness. Offering the patient a mirror to follow along during the examination may help with patient education about normal anatomy and aid in pinpointing painful areas.
If a clinician dismisses your pain, performs an uncomfortable pelvic exam without explanation, or does not ask where and when the pain occurs – seek a second opinion. This is a complex clinical area that deserves specialist attention.
Evidence-Based Treatment Options
Local vaginal estrogen is the foundational treatment for GSM-related dyspareunia. It restores tissue health, elasticity, and moisture – directly addressing the most common cause of entry dyspareunia in postmenopausal women – with minimal systemic absorption.
Vaginal DHEA (prasterone) and ospemifene offer alternatives for women who cannot or prefer not to use vaginal estrogen, with ospemifene being an oral daily tablet and DHEA a vaginal suppository.
Pelvic floor physiotherapy is essential for any dyspareunia involving pelvic floor involvement – which is most of it. A trained pelvic physiotherapist can identify whether the pelvic floor is weak, hypertonic, poorly coordinated, or a combination, and provide targeted treatment including manual therapy, biofeedback, and a progressive dilator program where appropriate.
Cognitive-behavioral therapy (CBT) addresses the fear-avoidance cycle, catastrophizing, and the psychological dimensions of chronic pain. Successful multidisciplinary treatment of vaginismus may include cognitive behavior therapy, psychotherapy, relationship and sexual counselling, vaginal lubricants, and sequential vaginal dilator therapy.
Topical anesthetics and compounded preparations – including topical lidocaine, compounded estradiol/testosterone creams, and others – may be prescribed by specialists for specific indications such as vestibulodynia.
What You Should Know Before Your Next Appointment
Pain during sex is not something you caused. It is not a relationship problem disguised as a physical one. It is not something you need to endure. It is a medical condition with identifiable causes and effective treatments – and you deserve to have it properly assessed and addressed.
If your current healthcare provider has not asked, ask them. If they minimize it, find someone who will not.
For more useful articles and expert guidance, explore the Womeno app – your personal digital companion through the hormonal transition. Download the app HERE.
Sources: Jorge CH et al. Pelvic floor muscle training as treatment for female sexual dysfunction: a systematic review and meta-analysis. American Journal of Obstetrics and Gynecology. 2024;231(1):51–66. doi:10.1016/j.ajog.2024.01.006; Faucher S et al. Investigating the role of the pelvic floor muscles in sexual function and sexual response: a systematic review and meta-analysis. Journal of Sexual Medicine. 2024;21(3):217–239.; Pruccoli J et al. Female Orgasmic Disorder: How Far We Have [Not] Come? International Urogynecology Journal. 2025. doi:10.1007/s00192-025-06206-x; Nappi RE et al. GSM: Recommendations from the 5th ICSM 2024. Sexual Medicine Reviews. 2026;14(1). doi:10.1093/smr/qeaf055; Chubak B. Dyspareunia: From Concept to Care. AUA News. April 2024. auanews.net; Iglesias-Rios L et al. Evaluation and Treatment of Female Sexual Pain: A Clinical Review. PMC5969816. 2018.; Danan ER et al. Dyspareunia in Women. American Family Physician. 2021;103(10):597–604.; Mertens HJ et al. The Relationship Between Pelvic Floor Function and Sexual Function in Perimenopausal Women. PMC8766258. 2022.; Vidal A et al. Female Sexual Function and Pelvic Floor Muscle Training: A Narrative Review. PMC12247012. 2025.; Allen RE et al. Effects of age, menopause, and comorbidities on neurological function of the female genitalia. International Journal of Impotence Research. 2004. doi:10.1038/sj.ijir.3901230; Mües HM et al. Too stressed for sex? Associations between stress and sex in daily life. Psychoneuroendocrinology. 2025. doi:10.1016/j.psyneuen.2024.106045; Sbarra DA, Coan JA. Bidirectional associations between daily subjective stress and sexual desire, arousal, and activity. Annals of Behavioral Medicine. 2025. doi:10.1093/abm/kaaf007; Hamilton LD et al. Cortisol, Sexual Arousal, and Affect in Response to Sexual Stimuli. Journal of Sexual Medicine. 2008.; Rodríguez-Nieto G et al. The modulatory role of cortisol in the regulation of sexual arousal. Frontiers in Behavioral Neuroscience. 2020;14:552567.Image by freepik